Table 2.
Baseline characteristics of patients.
| Control group (n = 83) | Intervention group (n = 88) | P | |
|---|---|---|---|
| Age (yrs) | 56 (49–73) | 59 (53–74) | 0.14 |
| Male (n, %) | 51 (61.45) | 57 (64.77) | 0.652 |
| BMI | 23.67 ± 2.93 | 22.97 ± 3.40 | 0.158 |
| 28-day mortality (n, %) | 29 (34.94) | 18 (20.45) | 0.034 |
| Platelet (×109/L) | 79.61 ± 49.69 | 70.51 ± 58.92 | 0.326 |
| PT (s) | 25.72 ± 7.34 | 22.66 ± 8.46 | 0.263 |
| Fibrinogen (g/L) | 2.64 ± 1.47 | 2.57 ± 1.93 | 0.17 |
| D-dimer (mg/L) | 4.7 (1.85–8.62) | 5.2 (2.12–9.53) | 0.192 |
| INR | 1.79 ± 0.91 | 1.71 ± 0.88 | 0.607 |
| MEDS score | 11 (8–19) | 12 (9–21) | 0.794 |
| APACHE II score | 24 (15–32) | 26 (16–35) | 0.334 |
| Type of infection (n, %) | |||
| Pneumonia | 39 (46.88) | 49 (55.68) | 0.256 |
| IAI | 37 (44.58) | 33 (37.5) | 0.347 |
| USI | 7 (8.43) | 6 (6.82) | 0.69 |
BMI: body mass index; PT: prothrombin time; INR: international normalized ratio; MEDS score: Mortality in Emergency Department Sepsis score; APACHE II score: Acute Physiology and Chronic Health Evaluation II score; IAI: intra-abdominal infection; USI: urinary system infection.